Krystal Biotech, Inc. (KRYS)
261.76
+0.81
(+0.31%)
USD |
NASDAQ |
Apr 06, 16:00
261.76
0.00 (0.00%)
After-Hours: 16:30
Krystal Biotech SG&A Expense (TTM) : 146.91M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 383.49M |
| Scholar Rock Holding Corp. | 176.20M |
| Alkermes Plc | 701.52M |
| Stoke Therapeutics, Inc. | 67.09M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |